AWS Taps Ginkgo Bioworks (NYSE: DNA), Twist Bioscience (NASDAQ: TWST) for New "Amazon Bio Discovery" Platform

• AWS has launched Amazon Bio Discovery, a new application that integrates 40+ AI biological foundation models with a physical lab network to slash antibody design time from years to weeks.
• Ginkgo Bioworks (DNA) and Twist Bioscience (TWST) are featured as inaugural integrated lab partners, allowing researchers to transition from AI-generated designs to physical synthesis and testing with a few clicks